Synthesis and antiarrhythmic activity of new benzofuran derivatives. 1981

G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles

Various 5-aminobenzofuran derivatives were prepared from khellin and screened intravenously in the dog for their potential antiarrhythmic activity against ouabain-induced ventricular arrhythmia and in the Harris test. From systematic structural variations it was found that two methoxy groups in positions 4 and 7 on the benzofuran ring, a tertiary aminoethoxy side chain in position 6, and a N-methylurea group in position 5 led to the most active compounds. These were then tested orally in the Harris test in the dog. The two long-acting derivatives N-[4,7-dimethoxy-6-(2-pyrrolidinoethoxy)-5-benzofuranyl]-N'-methylurea (8j) and N-[4,7-dimethoxy-6-(2-piperidinoethoxy)-5-benzofuranyl]-N'-methylurea (8m) showed advantages when compared to quinidine and disopyramide and have been selected for further studies.

UI MeSH Term Description Entries
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001572 Benzofurans Compounds that contain a BENZENE ring fused to a furan ring. Coumarones,Diphenylbenzofuran

Related Publications

G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
December 1993, Arzneimittel-Forschung,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
January 1985, Arzneimittel-Forschung,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
August 2011, European journal of medicinal chemistry,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
January 1989, Acta poloniae pharmaceutica,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
May 1983, Il Farmaco; edizione scientifica,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
July 1971, Arzneimittel-Forschung,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
July 1977, Journal of medicinal chemistry,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
November 2008, Archiv der Pharmazie,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
December 2005, European journal of medicinal chemistry,
G Bourgery, and P Dostert, and A Lacour, and M Langlois, and B Pourrias, and J Tisne-Versailles
September 1982, Journal of pharmaceutical sciences,
Copied contents to your clipboard!